188
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Synthesis, characterization and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and EGFR downregulation

, ORCID Icon, , , , & show all
Pages 39-54 | Received 05 Apr 2019, Accepted 03 Dec 2019, Published online: 13 Dec 2019
 

Abstract

Chrysin amino acid derivatives were synthesized to evaluate for their antiproliferative activities. Among them, N-(7-((5-hydroxy-4-oxo-2-phenyl-4H-chromen-7-yl)oxy)valeryl)-L-leucine (8c) displayed the most remarkable inhibitory activities against MCF-7 cells with IC50 values of 16.6 μM. Preliminary mechanistic studies showed that 8c could inhibit the colony formation and migration of MCF-7 cells. Flow cytometry analysis demonstrated that 8c mediated cell apoptosis and the prolongation of cell cycle progression in G1/S-phase against MCF-7 cells. Besides, 8c displayed the moderate inhibition against EGFR. Western blot assay suggested that 8c significantly inhibited EGFR phosphorylation. Molecular docking showed that 8c can bind the EGFR kinase well.

Disclosure statement

The authors declare that there are no conflicts of interest.

Additional information

Funding

We are grateful to the Hunan Provincial Department of Education Key Project (18A244), the University of South China Students Research Learning and Innovative Experimental Project (2018XJXZ200),Graduate student science foundation of University of South China (2018496) and the University of South China Students Research Learning and Innovative Experimental Project (2018XJXZ359) for financial support.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.